XML 44 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating Activities    
Net income $ 13,803 $ 7,987
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization and accretion (1,634) (1,130)
Provision for loan losses 1,363 1,738
Depreciation of premises and equipment 1,478 1,399
Deferred income tax expense 752 (1,151)
Net periodic employee benefit cost 179 329
Realized investment securities gains (83) (84)
Stock-compensation expense 572 457
Increase in value of bank-owned life insurance (756) (812)
Loans originated for sale (940) (11,554)
Proceeds from the sale of loans originated for sale 1,672 14,630
Gain on sale of loans (49) (298)
Change in accrued interest receivable (977) (615)
Change in other assets (3,629) 4,417
Change in other liabilities (5,240) (620)
Net Cash Provided by Operating Activities 6,511 14,693
Investing Activities    
Proceeds from sales of securities available-for-sale 129 488
Proceeds from maturities and calls of securities available-for-sale 13,885 46,205
Proceeds from maturities and calls of securities held-to-maturity 0 5,083
Purchases of securities available-for-sale (10,262) (488)
Payments to Acquire Held-to-maturity Securities (10,226) 0
Net decrease in loans 49,511 16,391
Purchases of premises and equipment (356) (1,700)
Acquisitions, net of cash acquired 0 (21,849)
Net Cash Provided by Investing Activities 42,681 44,130
Financing Activities    
Net increase in noninterest-bearing deposits 17,178 53,065
Net increase in interest-bearing deposits 27,430 39,138
Net (decrease) increase in short-term borrowings (15,885) 1,781
Purchases of treasury stock (2,936) 0
Proceeds from exercise of stock options 199 1,397
Dividends paid (5,827) (5,461)
Net Cash Provided by Financing Activities 20,159 89,920
Increase in Cash and Cash Equivalents 69,351 148,743
Cash and cash equivalents at beginning of period 85,876 84,994
Cash and Cash Equivalents at End of Period $ 155,227 $ 233,737